Saturna Capital Corp Astrazeneca PLC Transaction History
Saturna Capital Corp
- $7.24 Billion
- Q4 2024
A detailed history of Saturna Capital Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Saturna Capital Corp holds 1,637,345 shares of AZN stock, worth $124 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
1,637,345
Previous 1,674,852
2.24%
Holding current value
$124 Million
Previous $131 Million
17.8%
% of portfolio
1.48%
Previous 1.74%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,367Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.56 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...